Traditional angiogenesis inhibitors, such as antibodies blocking the vascular endothelial growth factor (VEGF) or VEGF receptor, inhibit the formation of new blood vessels or destroy existing vessels to starve tumor cells. This evidence concerns the gene VEGFA and neoplasm.